Koyfin Home > Directory > Health Care > Alder Biopharma > Price / Book

Alder Biopharma Price / Book Chart (ALDR)

Alder Biopharma annual/quarterly Price / Book from 2014 to 2019. Price-to-book value (P/B) is the ratio of market value of a company's shares (share price) over its book value of equity. The book value of equity, in turn, is the value of a company's assets expressed on the balance sheet.
  • Alder Biopharma Price / Book for the quarter ending October 10, 2019 was 14.31 a 0.05% increase of 0.01 year over year
  • Alder Biopharma Price / Book for the last 12 months ending October 10, 2019 was 14.31 a 0.05% increase of 0.01 year over year
  • Alder Biopharma Annual Price / Book for 2019 was 14.31 a -0.21% decrease of -0.03 from 2018
  • Alder Biopharma Annual Price / Book for 2019 was 14.34 a 0.11% increase of 0.02 from 2018
  • Alder Biopharma Annual Price / Book for 2019 was 14.33 a 0.16% increase of 0.02 from 2018
Other Valuation Metrics:
  • Alder Biopharma Market Cap for the quarter ending March 03, 2018 was $862m a 33.01% increase of 284m year over year
  • Alder Biopharma Enterprise Value for the quarter ending March 03, 2018 was $585m a 50.86% increase of 298m year over year
View Chart On Koyfin

Quarterly ALDR Price / Book Data

10/201914.31
10/201914.34
10/201914.33
10/201914.30
10/201914.31
10/201914.34
10/201914.30
10/201914.31
10/201914.35
10/201914.30

Annual ALDR Price / Book Data

201914.31
201914.34
201914.33
201914.30
201914.31
201914.34
201914.30
201914.31
201914.35
201914.30